Ricardo Fernández-de-Misa Cabrera

12PUBLICATIONS
33CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Haematological tumoursAllergyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 11, 2025
Safety of sonidegib in elderly patients with locally advanced basal cell carcinoma: A multicentre study.

Luisa Martos-Cabrera, Montserrat Bonfill-Ortí, Gustavo Deza

|Jun 05, 2025
Response to Sonidegib in Advanced Basal Cell Carcinomas by Histological Subtype: A Real-World Cohort.

Ana Jiménez-Sánchez, Óscar Muñoz Moreno-Arrones, Sonia Béa-Ardebol

|Apr 30, 2025
Germline PDCDL1 Gene Variants Are Associated with Increased Primary Melanoma Thickness.

Elizabeth Córdoba-Lanús, Omar García-Pérez, Leticia Melgar-Vilaplana

|Mar 11, 2025
Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study.

Lía Bejarano, Mercè Grau-Pérez, Marina Paíno-Román

|Apr 27, 2023
Ocrelizumab, an alternative to rituximab in refractory pemphigus vulgaris management.

E de-la-Rosa-Fernández, I Loizate-Sarrionandia, J González-Rodríguez

|Aug 26, 2022
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry.

Cristina Muniesa, Fernando Gallardo, Ignacio García-Doval

Pageof 2